Novo Nordisk A/S Overview
Company Headquarters: Bagsværd, Denmark
Founded: 1923
Workforce: ~43,258
Company Working: Novo Nordisk A/S (Novo Nordisk) is a Danish pharmaceutical company that discovers, manufactures, and commercializes pharmaceutical products. The company’s operating segments are diabetes, hemophilia, growth disorders, obesity, and other biopharmaceuticals. The company has research and development centers in China, India, Denmark, the UK, and the US. It has a strong clinical pipeline of drugs for conditions such as Type 1 diabetes, Type 2 diabetes, obesity, atherosclerosis, and hemophilia and growth disorders. The company operates in 79 countries and markets its products in more than 170 countries.



